Skip to main content
Erschienen in: Der Pathologe 6/2016

28.09.2016 | Endometriumkarzinom | Schwerpunkt: Uteruspathologie

Fallstricke bei der histopathologischen Diagnostik des Endometriumkarzinoms und seiner Vorstufen

Klinisch wichtige Differenzialdiagnosen, Vermeidung falsch-positiver Diagnosen

verfasst von: Prof. Dr. F. Kommoss, S. F. Lax

Erschienen in: Die Pathologie | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Zusammenfassung

Histopathologische Fehldiagnosen können bei Läsionen des Endometriums unnötigerweise zu unerwünschtem Verlust der Fertilität und therapieassoziierter Morbidität führen. Es ist daher wesentlich, Endometriumkarzinome sicher zu typisieren sowie von Vorstufen, benignen Läsionen und Artefakten abzugrenzen. In dieser Arbeit werden typische diagnostische „pitfalls“ abgehandelt. Eine sorgfältige Beachtung makroskopischer und histopathologischer Merkmale kann behilflich sein, klinische Fehlentscheidungen durch Berücksichtigung entscheidender Differenzialdiagnosen zu vermeiden. Hierzu gehören die Differenzialdiagnose hoch differenzierter endometrioider Adenokarzinome und der atypischen Endometriumhyperplasie, des myoinvasiven endometrioiden Adenokarzinoms und des atypischen polypoiden Adenomyoms sowie endometrioider und glandulär strukturierter seröser Adenokarzinome des Endometriums. Zudem gilt es, an die Möglichkeit falsch-positiver Hyperplasie- oder Karzinomdiagnosen infolge biopsiebedingter Artefakte zu denken.
Literatur
1.
Zurück zum Zitat Allison KH, Reed SD, Voigt LF et al (2008) Diagnosing endometrial hyperplasia: Why is it so difficult to agree? Am J Surg Pathol 32(5):691–698CrossRefPubMedPubMedCentral Allison KH, Reed SD, Voigt LF et al (2008) Diagnosing endometrial hyperplasia: Why is it so difficult to agree? Am J Surg Pathol 32(5):691–698CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Baak JP et al (2005) The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer 103(11):2304–2312CrossRefPubMedPubMedCentral Baak JP et al (2005) The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer 103(11):2304–2312CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15(1):10–17CrossRefPubMed Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15(1):10–17CrossRefPubMed
4.
Zurück zum Zitat Colombo N, Creutzberg C, Amant F et al (2016) ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. Int J Gynecol Cancer 26(1):2–30CrossRefPubMed Colombo N, Creutzberg C, Amant F et al (2016) ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. Int J Gynecol Cancer 26(1):2–30CrossRefPubMed
5.
Zurück zum Zitat Darvishian F, Hummer AJ, Thaler HT et al (2004) Serous endometrial cancers that mimic endometrioid adenocarcinomas: A clinicopathologic and immunohistochemical study of a group of problematic cases. Am J Surg Pathol 28(12):1568–1578CrossRefPubMed Darvishian F, Hummer AJ, Thaler HT et al (2004) Serous endometrial cancers that mimic endometrioid adenocarcinomas: A clinicopathologic and immunohistochemical study of a group of problematic cases. Am J Surg Pathol 28(12):1568–1578CrossRefPubMed
6.
Zurück zum Zitat Ellenson LH, Ronnett BM, Kurman RJ (2011) Precursor lesions of endometrial carcinoma. In: Kurman RJ, Ellenson LH, Ronnett BM (Hrsg) Blaustein’s pathology of the female genital tract, 6. Aufl. Springer, New York, S 359–391CrossRef Ellenson LH, Ronnett BM, Kurman RJ (2011) Precursor lesions of endometrial carcinoma. In: Kurman RJ, Ellenson LH, Ronnett BM (Hrsg) Blaustein’s pathology of the female genital tract, 6. Aufl. Springer, New York, S 359–391CrossRef
7.
Zurück zum Zitat Ellenson LH et al (2011) Endometrial carcinoma. In: Blaustein A, Kurman RJ (Hrsg) Blaustein’s pathology of the female genital tract, 6. Aufl. Springer, New York, S 393–451 Ellenson LH et al (2011) Endometrial carcinoma. In: Blaustein A, Kurman RJ (Hrsg) Blaustein’s pathology of the female genital tract, 6. Aufl. Springer, New York, S 393–451
8.
Zurück zum Zitat Gadducci A, Spirito N, Baroni E et al (2009) The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: A debated therapeutic option. Gynecol Endocrinol 25(10):683–691CrossRefPubMed Gadducci A, Spirito N, Baroni E et al (2009) The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: A debated therapeutic option. Gynecol Endocrinol 25(10):683–691CrossRefPubMed
9.
Zurück zum Zitat Gressel GM, Parkash V, Pal L (2015) Management options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancer. Int J Gynaecol Obstet 131(3):234–239CrossRefPubMed Gressel GM, Parkash V, Pal L (2015) Management options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancer. Int J Gynaecol Obstet 131(3):234–239CrossRefPubMed
10.
Zurück zum Zitat Garg K, Soslow RA (2012) Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium. Adv Anat Pathol 19(1):1–10CrossRefPubMed Garg K, Soslow RA (2012) Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium. Adv Anat Pathol 19(1):1–10CrossRefPubMed
11.
Zurück zum Zitat Gilks CB, Oliva E, Soslow RA (2013) Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma. Am J Surg Pathol 37(6):874–881CrossRefPubMed Gilks CB, Oliva E, Soslow RA (2013) Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma. Am J Surg Pathol 37(6):874–881CrossRefPubMed
12.
Zurück zum Zitat Guida M, Greco E, Di Spiezio Sardo A et al (2008) Successful pregnancy after four-step hysteroscopic technique for the treatment of atypical polypoid adenomyoma. Fertil Steril 89(5):1283–1284PubMed Guida M, Greco E, Di Spiezio Sardo A et al (2008) Successful pregnancy after four-step hysteroscopic technique for the treatment of atypical polypoid adenomyoma. Fertil Steril 89(5):1283–1284PubMed
13.
Zurück zum Zitat Hall JB et al (1984) The prognostic significance of adenomyosis in endometrial carcinoma. Gynecol Oncol 17(1):32–40CrossRefPubMed Hall JB et al (1984) The prognostic significance of adenomyosis in endometrial carcinoma. Gynecol Oncol 17(1):32–40CrossRefPubMed
14.
Zurück zum Zitat Heatley MK (2006) Atypical polypoid adenomyoma: A systematic review of the English literature. Histopathology 48(5):609–610CrossRefPubMed Heatley MK (2006) Atypical polypoid adenomyoma: A systematic review of the English literature. Histopathology 48(5):609–610CrossRefPubMed
15.
Zurück zum Zitat Jacques SM, Lawrence WD (1990) Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: A clinicopathologic study of 23 cases. Gynecol Oncol 37(3):401–407CrossRefPubMed Jacques SM, Lawrence WD (1990) Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis: A clinicopathologic study of 23 cases. Gynecol Oncol 37(3):401–407CrossRefPubMed
16.
Zurück zum Zitat Kelly MG et al (2005) Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol 98(3):353–359CrossRefPubMed Kelly MG et al (2005) Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol 98(3):353–359CrossRefPubMed
17.
Zurück zum Zitat Kendall BS et al (1998) Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 22(8):1012–1019CrossRefPubMed Kendall BS et al (1998) Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 22(8):1012–1019CrossRefPubMed
18.
Zurück zum Zitat Kurman RJ, Norris HJ (1982) Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49(12):2547–2559CrossRefPubMed Kurman RJ, Norris HJ (1982) Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49(12):2547–2559CrossRefPubMed
19.
Zurück zum Zitat Kurman RJ et al (1985) The behavior of endometrial hyperplasia. A long-term study of „untreated“ hyperplasia in 170 patients. Cancer 56(2):403–412CrossRefPubMed Kurman RJ et al (1985) The behavior of endometrial hyperplasia. A long-term study of „untreated“ hyperplasia in 170 patients. Cancer 56(2):403–412CrossRefPubMed
20.
Zurück zum Zitat Kurman RJ, Carcangiu ML, Herrington CS (Hrsg) (2014) WHO classification of tumours of female reproductive organs. IARC, Lyon Kurman RJ, Carcangiu ML, Herrington CS (Hrsg) (2014) WHO classification of tumours of female reproductive organs. IARC, Lyon
21.
Zurück zum Zitat Lavie O et al (2010) BRCA germline mutations in women with uterine serous carcinoma – still a debate. Int J Gynecol Cancer 20(9):1531–1534PubMed Lavie O et al (2010) BRCA germline mutations in women with uterine serous carcinoma – still a debate. Int J Gynecol Cancer 20(9):1531–1534PubMed
22.
Zurück zum Zitat Longacre TA et al (1995) Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion. Am J Surg Pathol 19(4):371–406CrossRefPubMed Longacre TA et al (1995) Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion. Am J Surg Pathol 19(4):371–406CrossRefPubMed
23.
Zurück zum Zitat Malpica A (2012) Preneoplastic conditions of the endometrium: Endometrial hyperplasia, the emergent concept of endometrial intraepithelial neoplasia, and others. In: Sienko A (Hrsg) Advances in surgical pathology, third series, endometrial cancer. Wolters Cluver/Lippincott Williams & Wilkins, Philadelphia, S 29–30 Malpica A (2012) Preneoplastic conditions of the endometrium: Endometrial hyperplasia, the emergent concept of endometrial intraepithelial neoplasia, and others. In: Sienko A (Hrsg) Advances in surgical pathology, third series, endometrial cancer. Wolters Cluver/Lippincott Williams & Wilkins, Philadelphia, S 29–30
24.
Zurück zum Zitat Matsumoto T, Hiura M, Baba T et al (2013) Clinical management of atypical polypoid adenomyoma of the uterus. A clinicopathological review of 29 cases. Gynecol Oncol 129(1):54–57CrossRefPubMed Matsumoto T, Hiura M, Baba T et al (2013) Clinical management of atypical polypoid adenomyoma of the uterus. A clinicopathological review of 29 cases. Gynecol Oncol 129(1):54–57CrossRefPubMed
25.
Zurück zum Zitat Mazur MT (1981) Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 5(5):473–482CrossRefPubMed Mazur MT (1981) Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 5(5):473–482CrossRefPubMed
27.
Zurück zum Zitat Mills AM et al (2014) Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol 38(11):1501–1509CrossRefPubMedPubMedCentral Mills AM et al (2014) Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Am J Surg Pathol 38(11):1501–1509CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Ordi J et al (2014) Reproducibility of current classifications of endometrial endometrioid glandular proliferations: Further evidence supporting a simplified classification. Histopathology 64(2):284–292CrossRefPubMed Ordi J et al (2014) Reproducibility of current classifications of endometrial endometrioid glandular proliferations: Further evidence supporting a simplified classification. Histopathology 64(2):284–292CrossRefPubMed
29.
Zurück zum Zitat Ota S et al (2003) Molecular pathology of atypical polypoid adenomyoma of the uterus. Hum Pathol 34(8):784–788CrossRefPubMed Ota S et al (2003) Molecular pathology of atypical polypoid adenomyoma of the uterus. Hum Pathol 34(8):784–788CrossRefPubMed
30.
Zurück zum Zitat Pennington KP et al (2013) BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer 119(2):332–338CrossRefPubMed Pennington KP et al (2013) BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma. Cancer 119(2):332–338CrossRefPubMed
31.
Zurück zum Zitat Rahimi S et al (2009) Endometrial polyps and the risk of atypical hyperplasia on biopsies of unremarkable endometrium: A study on 694 patients with benign endometrial polyps. Int J Gynecol Pathol 28(6):522–528CrossRefPubMed Rahimi S et al (2009) Endometrial polyps and the risk of atypical hyperplasia on biopsies of unremarkable endometrium: A study on 694 patients with benign endometrial polyps. Int J Gynecol Pathol 28(6):522–528CrossRefPubMed
32.
Zurück zum Zitat Robert-Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg) (2010) Krebs in Deutschland 2005/2006. Häufigkeiten und Trends, 7. Aufl. Robert-Koch-Institut, Deutschland Robert-Koch-Institut, Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. (Hrsg) (2010) Krebs in Deutschland 2005/2006. Häufigkeiten und Trends, 7. Aufl. Robert-Koch-Institut, Deutschland
33.
Zurück zum Zitat Silverberg SG (2000) Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod Pathol 13(3):309–327CrossRefPubMed Silverberg SG (2000) Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod Pathol 13(3):309–327CrossRefPubMed
34.
Zurück zum Zitat Soslow RA, Chung MH, Rouse RV et al (1996) Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix: An immunohistochemical study. Int J Gynecol Pathol 15(3):209–216CrossRefPubMed Soslow RA, Chung MH, Rouse RV et al (1996) Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix: An immunohistochemical study. Int J Gynecol Pathol 15(3):209–216CrossRefPubMed
35.
Zurück zum Zitat Von Numers C (1949) On the traumatic effect of curettage on the endometrial biopsy, with special reference to so-called invagination pictures and the crumbling endometrium. Acta Obstet Gynecol Scand 28(3–4):305–313CrossRef Von Numers C (1949) On the traumatic effect of curettage on the endometrial biopsy, with special reference to so-called invagination pictures and the crumbling endometrium. Acta Obstet Gynecol Scand 28(3–4):305–313CrossRef
36.
Zurück zum Zitat Wheeler DT et al (2000) Minimal uterine serous carcinoma: Diagnosis and clinicopathologic correlation. Am J Surg Pathol 24(6):797–806CrossRefPubMed Wheeler DT et al (2000) Minimal uterine serous carcinoma: Diagnosis and clinicopathologic correlation. Am J Surg Pathol 24(6):797–806CrossRefPubMed
37.
Zurück zum Zitat Young RH et al (1986) Atypical polypoid adenomyoma of the uterus. A report of 27 cases. Am J Clin Pathol 86(2):139–145CrossRefPubMed Young RH et al (1986) Atypical polypoid adenomyoma of the uterus. A report of 27 cases. Am J Clin Pathol 86(2):139–145CrossRefPubMed
38.
Zurück zum Zitat Zheng W et al (2011) A proposed model for endometrial serous carcinogenesis. Am J Surg Pathol 35(1):e1–e14CrossRefPubMed Zheng W et al (2011) A proposed model for endometrial serous carcinogenesis. Am J Surg Pathol 35(1):e1–e14CrossRefPubMed
Metadaten
Titel
Fallstricke bei der histopathologischen Diagnostik des Endometriumkarzinoms und seiner Vorstufen
Klinisch wichtige Differenzialdiagnosen, Vermeidung falsch-positiver Diagnosen
verfasst von
Prof. Dr. F. Kommoss
S. F. Lax
Publikationsdatum
28.09.2016
Verlag
Springer Medizin
Erschienen in
Die Pathologie / Ausgabe 6/2016
Print ISSN: 2731-7188
Elektronische ISSN: 2731-7196
DOI
https://doi.org/10.1007/s00292-016-0236-y

Weitere Artikel der Ausgabe 6/2016

Der Pathologe 6/2016 Zur Ausgabe

Mitteilungen der Österreichischen Gesellschaft für Pathologie/Österreichischen Abteilung der IAP (ÖGPath/IAP Austria)

Mitteilungen der Österreichischen Gesellschaft für Pathologie/Österreichischen Abteilung der IAP (ÖGPath/IAP Austria)

Einführung zum Thema

Uteruspathologie

Das könnte Sie auch interessieren

15.09.2016 | Zervixkarzinom | Schwerpunkt: Uteruspathologie

Moderne Biomarker bei Präkanzerosen der Cervix uteri

Histologische-zytologische Korrelation und Einsatz

18.10.2016 | Pathologie | Einführung zum Thema

Uteruspathologie

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.